abstract |
The present invention relates to a new class of diketone compounds. The compound is a compound of formula I and pharmaceutically acceptable salts, prodrugs and solvates thereof, as well as pharmaceutical compositions comprising the compounds, and methods for their synthesis. In addition, the present invention relates to a pharmaceutical composition comprising the compound, which can be used to inhibit the activity of tumor-related target proteins or genes. |